ABSTRACT. The recognition of Cerebrovascular Disease (CVD) at earlier clinical stages may favor the control of vascular risk factors and prevention of dementia. However, operational criteria for symptomatic phases at non-dementia stages are often difficult, as the current criteria normally require the evidence of extensive subcortical disease. Objective: To identify the neuroimaging profile of Vascular Mild Cognitive Impairment (VaMCI), the impact of those aspects over cognition and the neuropsychological tests that distinguished VaMCI from other groups. Methods: Searches were performed in Scopus, ISI and PsycINFO, using the following key terms: "vascular mild cognitive impairment" OR "vascular cognitive impairment no dementia" OR "vascular cognitive impairment not demented" OR "subcortical mild cognitive impairment". Results: Of 249 papers, 20 studies were selected. Ten of those included only patients with severe White Matter Hyperintensities (WMH), whereas 10 others admitted subjects with moderate-to-severe WMH. Both groups showed poor performances in Executive Function (EF) tasks in comparison to normal controls and other diagnostic groups. Among EF tests, those assessing "complex" EF abilities consistently distinguished VaMCI from other groups, regardless of the severity of WMH. VaMCI subjects with severe or moderate-to-severe WMH showed cognitive deficits in comparison with other groups. "Complex" EF tests were the most useful in differentiating those patients from the other groups. Conclusion: The occurrence of VaMCI may be associated with the presence of CVD at moderate levels; the detection of vascular damage at earlier stages may allow the adoption of therapeutic actions with significant effect-sizes. Key words: cerebrovascular disorders, vascular dementia, cerebral infarction, neurological diagnostic techniques. 
Recent operational criteria, such as the 2011 American Heart Association (AHS)/American Stroke Association (ASA) scientific statement on vascular contributions to cognitive impairment, suggested that the relationship between CVD and cognitive changes could be characterized whether through the evidence of cognitive deficits succeeding a clinical stroke or through identifying vascular lesions on neuroimaging deemed severe enough to explain the cognitive impairment. . In this document, CVD was evidenced by the presence of one of the following changes: [1] extensive and confluent subcortical White Matter Hyperintensities (WMH); [2] large-vessel infarcts: 1 (for Mild VCD) or ≥2 (for Major VCD); [3] 1 strategically placed infarct (in the thalamus or basal ganglia); [4] >2 lacunar infarcts outside the brainstem or at least 1 lacune combined with extensive WMH; and (5) intracerebral hemorrhages: ≥2 or 1 strategically placed. 3 The VASCOG statement represented a more comprehensive neuroimaging criterion in comparison to the AHA/ASA recommendations and a substantial change in relation to the Erkinjuntti's neuroimaging criteria for Subcortical Ischemic VaD (2000) , in which extensive and confluent WMH or moderate WMH combined with at least 5 lacunes was required to characterize CVD. 4 Nonetheless, the persistence in the new criteria of the need for extensive and confluent WMH contrasted with some studies, which have suggested that moderate WMH with less than 5 lacunes could account for cognitive impairments. 5 As indicated by several studies, mild WMH is highly prevalent among normal elderly individuals and has not been significantly associated with cognitive changes. 6 One possible advantage in identifying CVD in its mildest clinical (VaMCI) and neuroimaging (moderate subcortical WMH and less than 5 lacunes) stages is the fact that progression of vascular damage might be preventable. Early detection might allow the adoption of disease-modifying therapies that could prevent the progression of vascular lesions; therefore, it might interrupt the advance of cognitive impairment that could result in VaD. Finally, recent diagnostic criteria for Va-CIND overlap with the ASA/AHA criteria for VaMCI, 7 thus the term VaMCI has been used in this review to refer to both constructs.
According to the above pondering, a systematic review was undertaken aiming: [1] to assess the neuroimaging profile of individuals classified as VaMCI in clinical studies; [2] to determine whether different neuroimaging criteria impact over cognitive findings, and [3] to identify neuropsychological tests that could distinguish VaMCI from normal controls or other diagnostic groups across studies using different criteria for CVD. The authors hypothesized that the choice of establishing the threshold of brain vascular lesions into moderate or severe stages of WMH may account for divergent cognitive findings among studies.
METHODS
Data search and selection. Studies were found through searches in Scopus, ISI Web Of Knowledge and PsycINFO, using the following key terms, in all fields and published in any date: "vascular mild cognitive impairment" OR "vascular cognitive impairment no dementia" OR "vascular cognitive impairment not demented" OR "subcortical mild cognitive impairment". This search strategy was augmented with hand searches of reference lists of included studies. More articles were obtained from directly contacting authors for relevant papers.
After the searches were performed, articles were included if they were: clinical studies, which included neuroimaging data from individuals with VaMCI; that compared cognitive performances between VaMCI and other diagnostic groups [VaD, AD, non-vascular MCI (non-VaMCI)] or normal controls; and written in English, French, Spanish or Portuguese.
The authors have excluded studies that: classified individuals as VaMCI based solely on clinical/ neuropsychological aspects (e.g., studies in which the cognitive deficits were judged to have vascular cause through clinical features, such as stepwise progression, sudden onset, gait disturbances, focal neurological signs or those that applied only an ischemic score to identify the presence of cerebrovascular disease); did not assess subjects with MCI, defined as those presenting cognitive impairments that do not fulfill criteria for dementia; did not acknowledge a detailed neuroimaging criterion for the diagnosis of VaMCI (e.g., cognitive impairment considered associated with vascular lesions through subjective evaluation from an expert); did not compare cognitive performances between VaMCI and controls or other diagnostic groups; or included subjects with cortical infarction or cortical atrophy suggestive of large-vessel or neurodegenerative diseases. The current study followed the standard protocols of PRISMA statement.
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Data extraction. Data were extracted from full-texts by one author (FKS) and reviewed by a second author (EE). Divergences were furtherly discussed among the entire team of authors.
RESULTS
Of a total of 249 retrieved papers, 20 studies were selected for data extraction. Figure 1 summarizes the stages of data search and selection.
Clinical criteria for MCI. Participants in the studies presented objective cognitive deficits and preserved functional status. Mild differences included articles that identified those with cognitive impairments based on performances in screening tests for cognitive deficits (e.g., MMSE ≥ 24, CDR= 0.5, Clock Drawing Test scores lower than 2/6). [9] [10] [11] [12] [13] [14] Cognitive impairment was defined as performances 1 to 2 standards deviations (between the 16 th and the 2 nd percentile) below mean normative values, in some studies. [15] [16] [17] [18] [19] [20] [21] Few studies, all of them prior to 2009, required impairment in memory for diagnosis of MCI; 17, 22, 23 however, most papers did not include any specific cognitive domain or proposed dysexecutive symptoms as typically associated with VaMCI.
Neuroimaging criteria for subcortical vascular disease. Ten of the studies classified subcortical CVD as the presence of white-matter changes compatible with severe WMH and/or at least 5 subcortical lacunes. Five of those followed the criteria proposed by Erkinjuntti et al. (2000) for Binswanger's Disease, which requires the presence of severe WMH, periventricular lesions larger Erkinjuntti et al. (2000) was applied in two of the studies. CVD, in those cases, was represented by patchy or diffuse leukoaraiosis and at least one lacunar infarct on neuroimaging.
9,22 Evidence of extensive WMH, defined as lesions larger than 3 mm of diameter in the semioval center and larger than 5 mm in the deep gray nuclei, was the criterion used in one study. 26 Other methods for identification of individuals with severe WMH included semiautomatic whitematter volumetry techniques. Nordahl et al. (2005) classified individuals with WMH extending for more than 19.375% of total white-matter volume as presenting severe WMH. 23 Moretti et al. (2008) computed the presence of CVD by counting voxels corresponding to WMH and identifying those individuals whose lesions corresponded to values over the fourth quartile of volume damage.
10 Table 1 illustrates those findings. Moderate WMH and/or less than 5 lacunes were deemed sufficient to characterize CVD in ten of the studies. Overall, individuals that scored 2 or more in the modified-Fazekas Scale, corresponding to the presence of moderate periventricular WMH ("smooth halo") with beginning confluent deep WMH, were selected for those studies. Identification of at least 2 lacunar infarcts was an alternative criterion for diagnosis of moderately severe cerebrovascular disease. Table 2 depicts those results.
Cognitive performances and neuroimaging criteria. Although the choice of neuropsychological tests varied across studies, cognitive assessment in most cases included tasks that measured executive function (EF), memory, language and visuospatial/ visuoconstructive abilities. Table 3 summarizes the main affected cognitive abilities in the selected studies. EF has been divided into 3 components, following studies that performed a latent variable approach of multiple EF measures: "shifting" (switching between tasks), "inhibition" (deliberate overriding of prepotent responses) and "working memory/updating" (monitoring and rapidly changing new contents). 27 Tests categorized as "less specific EF tests" included tasks that assessed multiple EF dimensions (e.g., Clock Drawing Test, Verbal Fluency etc.), instead of measuring one single aspect of it. 28 Matching between neuropsychological tests and cognitive domains was made in accordance with evidences in the literature. 21, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] 
DISCUSSION
The idea that VCI comprises a spectrum of different stages of vascular-related cognitive impairment may suggest that dementia can be preceded by subtle cognitive changes associated with CVD. 41 However, the boundaries of vascular burden that mark the earliest clinical stages of CVD still need to be defined. The importance of establishing the milder pathological clinical phase of VCI resides in the fact that early identification of cognitive decline associated with CVD might allow adequate control of vascular risk factors, so as to prevent progression to dementia. In this perspective, the adoption of the neuroimaging criteria proposed by Erkinjuntti et al. for Binswanger Disease (2000) identified cases in which white-matter injury is already extensive, that may limit the effect-sizes of prophylactic actions. The present article reviewed data suggestive of expressive cognitive changes associated with moderateto-severe WMH and less than 5 lacunes. Identification of those subjects might allow more effective actions in preventing progression of cognitive decline.
Studies using either severe or moderate-to-severe CVD criteria demonstrated that EF performances could distinguish VaMCI from non-VaMCI, VaD and normal controls. Global and "impure" EF tasks, comprising instruments that assess multiple and complex EF abilities, such as planning, reasoning, decision-making and abstract thinking, appear to be more sensitive in discrimi- nating VaMCI from controls than specific and "pure" EF measures, even in the group with moderate WMH. Data from functional neuroimaging studies suggested that those "higher level" EF may recruit diverse areas in the prefrontal, parietal, medial and superior temporal cortices, and subcortical structures (amygdala, thalamus and cerebellum). 42, 43 These findings indicate that complex EF may result from the fine integration of many different cortical areas and subcortical regions, which depends on an extensive and delicate network of neural projections. 44 Moderate white-matter changes, represented by periventricular smooth halo and beginning confluent deep WMH on neuroimaging, may be sufficient to interrupt segments of inter-cortical and/or cortical-subcortical loops, leading to disconnection of areas associated with complex EF. 45 On the other hand, data on the accuracy of more specific EF measures in distinguishing controls, VaMCI and non-VaMCI appeared to be inconsistent, as observed in relation to shifting tasks. Performances in inhibition tasks were significantly worse in VaMCI subjects than in controls in most of the studies with moderate-to-severe CVD. This finding might suggest an early impairment of inhibitory control in VCI patients, which is in line with a previous prospective study. 46 Interconnections among prefrontal cortex, subcortical regions and posterior areas might be interrupted in those patients, leading to loss of prefrontal inhibitory inputs over cortical-subcortical networks associated with task-irrelevant distracters. 47, 48 Among the severe CVD group, only two studies performed a similar analysis, showing conflicting results. Furthermore, working memory tasks were consistently inaccurate in differentiating VaMCI from non-VaMCI in most studies. Reports of impairments in working memory in amnestic MCI are abundant in the literature; thus, both Vascular and amnestic MCI might share, through different pathological mechanisms, similar prefrontal and cingulate dysfunction associated with working memory abilities. 49 Non-executive cognitive domains were also tested in the studies. As expected, episodic memory tasks were more impaired in "atrophic" MCI than in VaMCI, in most of the studies. Yet, the finding that episodic memory performances were significantly poorer in VaMCI than in controls may highlight the role of the prefrontal cortex for the retrieval of information. Recent evidence suggested that left prefrontal cortex may participate in the recall process through the use of environmental cues and the ability to inhibit irrelevant memories during a task. 50 Also, not surprisingly, impairments in visuospatial and visuoconstructive abilities were more prominent in VaMCI than in non-VaMCI and controls. Those alterations have been associated with CVD in different studies. 51, 52 Finally, screening tests (MMSE) and global cognitive assessment instruments (CAMCOG, BMET) identified VaMCI from controls in many studies and also from non-VaMCI in a smaller number of articles. Differently from longer neuropsychological batteries, many studies reported ceiling-effects for MMSE in samples comprising singledomain MCI subjects. However, evidence suggested that it may present similar accuracy in detecting multidomain impairments as compared with the Montreal Cognitive Assessment (MoCA) and the Addenbrooke's Cognitive Examination-Revised (ACE-R). 53 Some other issues should be addressed. Despite slight variations, specially related to the instruments used to detect cognitive impairment and to the degree of deviation from normal cognition necessary to characterize the disorder, the clinical criteria proposed by Petersen et al. for MCI (2001) were adopted almost unchanged by most of the authors. 54 This fact might indicate that, albeit past criticisms were directed to the disorder's construct validity, the use of the clinical entity described by Petersen et al. has largely prevailed among clinical studies. 55 Conversely, other operational criteria have shown to be not optimal to identify MCI associated with CVD. There are limitations in this review that need to be commented. Different terminologies used to describe periventricular and deep WMH and imprecise expressions (e.g., "patchy WMH", "diffuse WMH", "smooth halo" and "caps"), present in different criteria make it difficult to compare lesion loads across studies. Furthermore, the characterization of periventricular/deep WMH itself has been object of divergence by some authors, who adopted different distances between the ventricle's margin and the lesion to define it as "periventricular" or "deep". 56, 57 Moreover, tasks classified as assessing a specific aspect of EF may not be pure measures of that process, since they commonly require other EF and non-EF features. Models of EF as a unique or multiple constructs have been proposed and there is no agreement regarding neuropsychological tests that may thoroughly assess all of its aspects. Further studies using confirmatory factoranalysis of EF measures may allow the establishment of cognitive batteries comprising tests that evaluate complementary processes of EF.
The present review evidenced that the choice of neuroimaging criteria to characterize CVD in MCI subjects did not result in groups with different cognitive profiles. One possible hypothesis is the complex nature of subcortical disease, in which vascular and non-vascular (e.g., Alzheimer's disease, multiple sclerosis) events often interact, ultimately resulting in WM disconnection and cognitive impairment. 58, 59 In addition, as suggested by Pasi et al. (2015) , that may also be due to the fact that cognitive tests may lose their accuracy in distinguishing groups of patients once certain degree of vascular lesions is reached. 60 In conclusion, evidence in the literature suggested that the use of moderate-to-severe WMH and less than 5 lacunar infarcts as the earliest pathological neuroimaging presentation of CVD appear to be appropriate. Future operational criteria for VCI, especially for VaMCI, should place more emphasis in the clinical relevance of the early diagnosis. As mentioned, this measure may allow early intervention over risk-factors, with opportune effect in preventing progression to VaD. 
